Ionis Pharmaceuticals (IONS) Accounts Payables (2009 - 2026)

Ionis Pharmaceuticals' Accounts Payables history runs 18 years deep, the most recent figure standing at $26.0 million for Q1 2026.

• In Q1 2026, Accounts Payables rose 49.12% year-over-year to $26.0 million; the TTM figure through Mar 2026 stood at $26.0 million (up 49.12% YoY), while the FY2025 annual figure was $28.1 million, down 34.64% from the prior year.
• Accounts Payables was $26.0 million for Q1 2026 at Ionis Pharmaceuticals, down from $28.1 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $43.0 million in Q4 2024 to a low of $5.6 million in Q3 2023.
• Historically, Accounts Payables has averaged $18.5 million across 5 years, with a median of $17.5 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Accounts Payables plunged 72.67% in 2023, then soared 146.67% in 2025.
• A 5-year view of Accounts Payables shows it stood at $17.9 million in 2022, then surged by 45.23% to $26.0 million in 2023, then soared by 65.07% to $43.0 million in 2024, then tumbled by 34.64% to $28.1 million in 2025, then fell by 7.31% to $26.0 million in 2026.
• The last three Accounts Payables figures came in at $26.0 million (Q1 2026), $28.1 million (Q4 2025), and $14.3 million (Q3 2025), per Business Quant data.